# Standard and Immunostimulating Enteral Nutrition in Surgical Patients

> **NCT00576940** · PHASE4 · COMPLETED · sponsor: **Jagiellonian University** · enrollment: 196 (actual)

## Conditions studied

- Gastric Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** Reconvan
- **DRUG:** Peptisorb

## Key facts

- **NCT ID:** NCT00576940
- **Lead sponsor:** Jagiellonian University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2007-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576940, "Standard and Immunostimulating Enteral Nutrition in Surgical Patients". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00576940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*